Cross-Cultural Validation of the Scales for Outcomes in Parkinson's Disease-Psychosocial Questionnaire (SCOPA-PS) in Four Latin American Countries
| Autor: | Francisco Javier Carod-Artal, Javier Virués-Ortega, Federico Micheli, Carolina Velázquez, Gloria Meza-Rojas, Marcos Serrano-Dueñas, Pablo Martinez-Martin, Gabriela Ruiz-Galeano |
|---|---|
| Jazyk: | angličtina |
| Předmět: |
Cross-Cultural Comparison
Male SCOPA-PS Internationality Psychometrics Parkinson's disease Scopa Anxiety Hospital Anxiety and Depression Scale Severity of Illness Index Cronbach's alpha Sickness Impact Profile Surveys and Questionnaires Adaptation Psychological Content validity medicine Humans Cultural Competency Aged Language PDQ-39 Depression CISI-PD Health Policy Public Health Environmental and Occupational Health Reproducibility of Results Parkinson Disease Cultural Diversity Middle Aged South America health-related quality of life Treatment Outcome Standard error Convergent validity Quality of Life Regression Analysis Female medicine.symptom Factor Analysis Statistical Psychology Psychosocial Stress Psychological Clinical psychology |
| Zdroj: | Value in Health. (2):385-391 |
| ISSN: | 1098-3015 |
| DOI: | 10.1111/j.1524-4733.2008.00436.x |
| Popis: | Objective: To conduct a cross-national validation of the Scales for Outcomes in Parkinson’s Disease-PsychoSocial questionnaire (SCOPA-PS) in four Latin American Countries. Methods: Data quality (missing items), scale assumptions (item–test correlation), internal consistency (Cronbach’s alpha, item homogeneity), factor structure, content validity, and precision (standard error of measurement, SEM) of the scale were explored, as was convergent validity with motor symptoms (Clinical Impression of Severity Index [CISI-PD], Scales for Outcomes in Parkinson’s Disease-Motor Scale), emotional status (Hospital Anxiety and Depression Scale) and health-related quality of life (Parkinson Disease Questionnaire-39). Known-groups validity was studied by category of severity, based on Hoehn and Yahr staging (HY), CISI-PD, and disease duration. Results: Three hundred thirty-one Parkinson’s disease (PD) patients with usable data participated (mean age 64.7 years; 42.3% female; mean PD duration 8.5 years; HY, 1 to 5). Data quality (missing items |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|